METLIFE INC
$70.97
+1.18%
MetLife declared its Q1 2026 dividend of $0.5675 per share while the stock trades around $69.16, with analysts projecting approximately 33% upside to the consensus average price target of $92.47, suggesting the stock is significantly undervalued on a fundamental basis. The insurance giant's diversified business across group benefits, retirement, and international markets provides stable earnings. Risks include potential credit losses in commercial real estate and corporate bond portfolios, lower-than-expected investment yields, and competitive pressure in the group benefits market.